Clinical Trial Update: Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) [NA]

View source ↗

Summary

This document provides a clinical trial update on the safety and performance evaluation of Medtronic's NMX8 automated insulin delivery system for people with in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NMX8 Automated Insulin Delivery System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes (Insulin-requiring, Type 1 or Type 2) | NA | Status: NOT_YET_RECRUITING